The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

Imdelltra is associated with improvement in overall survival compared to local standard-of-care chemotherapy among patients with small cell lung cancer.

If you or a loved one has recently received a diagnosis of non-small cell lung cancer, here are 10 terms you’ll want to know. Non-small cell lung cancer (NSCLC) and the many terms related to it ...

Tell your health care provider if you have symptoms of high blood sugar ... How Was Ensacove Studied for Non-Small-Cell Lung Cancer? The effectiveness of Ensacove was evaluated in a clinical ...

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung ...

A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due ...

Mesothelioma and lung cancer are different conditions that can be caused by asbestos. Learn more about mesothelioma vs. lung ...

Research Pinpoints Weakness in Lung Cancer's Defenses Feb. 10, 2025 — Scientists uncover an enzyme that boosts cancer cell metabolism ... the disease even before symptoms occur.

A panelist discusses how first-line (1L) therapies, including EGFR tyrosine kinase inhibitors (TKIs) such as osimertinib, are the standard of care for treating locally advanced or metastatic ...

Once non-small-cell lung cancer (NSCLC) spreads far and wide, treating it is kind of a balancing act. A cure isn't likely, but you can slow it down. So you aim to relieve your symptoms and improve ...